Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 CHF | -4.35% | -26.91% | +139.13% |
Apr. 24 | Top Premarket Decliners | MT |
Apr. 18 | Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024 |
Business Summary
Number of employees: 23
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Pharmaceutical Products
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Chairman | 75 | 09-04-15 | |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Chairman | 75 | 09-04-15 | |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Isaac Manke
BRD | Director/Board Member | 47 | 17-12-31 |
Ray Hill
BRD | Director/Board Member | 79 | 08-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 181,952,457 | 91,845,495 ( 50.48 %) | 59,159,103 ( 32.51 %) | 50.48 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADDEX THERAPEUTICS LTD 23.93% | 44,113,438 | 23.93% | 4,682,200 $ |
Company contact information
Addex Therapeutics Ltd.
9, Chemin des Mines Plan-les-Ouates
1202, Geneva
+41 22 884 1555
http://www.addextherapeutics.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+139.13% | 16.15M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+46.73% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ADXN Stock
- Company Addex Therapeutics Ltd